drugset / Trial / NCT00622752

Effects of EVT 302 With or Without NRT on Craving and Withdrawal in Healthy Male Smokers Deprived of Cigarettes

NCT00622752

Phase 2 Completed 90 enrolled Evotec Neurosciences GmbH
RandomizedCrossoverTriple-blindTreatment

Summary

This randomised, placebo-controlled study is designed to explore the effects of EVT 302 both with and without concomitant nicotine replacement therapy (NRT) on craving and withdrawal in smokers after short term deprivation of cigarettes.

Timeline

Start
2008-02
Primary completion
2008-05
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Subject EVT 302 Unknown 10 mg
Subject Nicotine Unknown 21 mg

Indications

No indication recorded.